AccuraGen Tech Stack

Liquid biopsy platform for personalized cancer diagnostics

Biotechnology San Jose, California 11–50 employees Founded 2013 Privately Held

AccuraGen develops liquid biopsy assays for early cancer detection and treatment selection. The tech stack—Python, C++, Rust, Java, Nextflow, Docker, Kubernetes on AWS—reflects a computational biology operation with heavy algorithmic work (variant-calling, MRD detection) and production infrastructure maturity. Active projects center on assay validation and regulatory readiness (CLIA/CAP), while pain points cluster around NGS workflow scaling and lab ops optimization, suggesting the company is transitioning from development toward clinical deployment.

Tech Stack 14 technologies

Core StackPython C++ Rust Java AWS GitHub Docker Kubernetes AWS Lambda Terraform CloudFormation Nextflow Bash Batch

What AccuraGen Is Building

◆Challenges

Regulatory readiness planning
Clia certification readiness
Cap accreditation readiness
High-throughput ngs workflow scaling
Laboratory operations optimization
Throughput and data quality improvement

▲Active Projects

Mrd-calling algorithm development
Novel molecular assay development
Somatic variant-calling algorithm improvement
Scalable pipeline integration
Clinical validation
Clia certification and cap accreditation readiness
Inspection preparedness
Laboratory build-out
Workflow standardization
Assay improvements

Hiring Activity

Steady7 roles · 3 in 30d

Department

Research

Data

Engineering

Healthcare

Ops

Seniority

Senior

Junior

Manager

Mid

Principal

Staff

Company intelligence

Find more companies like AccuraGen by tech stack, pain points and active projects

Get started free

About AccuraGen

AccuraGen is a liquid biopsy company founded in 2013, headquartered in San Jose with a second operations center in Shanghai. The platform uses blood-based biomarkers to enable earlier cancer diagnosis and personalized treatment decisions. With 11–50 employees split across research, data, engineering, healthcare, and operations, the company is actively building out laboratory infrastructure, standardizing workflows, and preparing for regulatory certification (CLIA/CAP accreditation). Current hiring is focused on research scientists and engineers to support assay development and clinical validation.

HeadquartersSan Jose, California

Company Size11–50 employees

Founded2013

Hiring MarketsUnited States

Frequently Asked Questions

What is AccuraGen's tech stack?

Python, C++, Rust, Java, Nextflow, Docker, Kubernetes, AWS Lambda, AWS Batch, Terraform, CloudFormation, GitHub, and Bash. The mix supports both genomic algorithm development and cloud-based bioinformatics pipeline orchestration.

What is AccuraGen working on?

MRD-calling and somatic variant-calling algorithms, novel molecular assay development, scalable pipeline integration, clinical validation, laboratory build-out, and CLIA/CAP certification readiness. Primary challenges include NGS workflow scaling and lab operations optimization.